Sign in

CIK 0001811063

  • Non-accelerated filer
  • Smaller reporting company

Nuvation Bio Inc.

Sign in to watch
Ticker
NUVB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850862255
Phone
+1 332-208-6102
Business address
1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
Former names
Panacea Acquisition Corp
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale CHIEF MEDICAL OFFICER sold 150,000 shares at $7.82 ($1,173,255)
  8. 4 Open-market sale CHIEF MEDICAL OFFICER sold 20,000 shares at an average $7.75 ($155,000)
  9. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 369,051 shares at $7.23 ($2,667,132)
  10. 4 Open-market sale CHIEF MEDICAL OFFICER sold 20,000 shares at $7.00 ($140,074)
  11. 4 Open-market sale CHIEF TECHNICAL OPERATIONS sold 200,000 shares at $7.14 ($1,427,680)
  12. 4 Open-market sale CHIEF MEDICAL OFFICER sold 30,000 shares at an average $4.93 ($148,028)
  13. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 100,000 shares at $5.02 ($502,460)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy CHIEF PEOPLE OFFICER bought 10,000 shares at $1.71 ($17,100)
  16. 4 Open-market buy Chief Financial Officer bought 7,300 shares at an average $1.81 ($13,216)
  17. 4 Open-market buy Chief Commercial Officer bought 50,000 shares at $1.81 ($90,350)
  18. 4 Open-market buy CHIEF REGULATORY OFFICER bought 50,000 shares at an average $1.79 ($89,740)
  19. 4 Open-market buy PRESIDENT AND CEO bought 500,000 shares at $1.79 ($893,500)
  20. 4 Derivatives Options or other derivatives

Page 2 of 10 · 184 filings